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Abstract
Application of green fluorescent protein (GFP) in a variety of biosystems as a unique bioindicator or biomarker has revolutionized
biological research and made groundbreaking achievements, while increasing evidence has shown alterations in biological
properties and physiological functions of the cells and animals overexpressing transgenic GFP. In this work, response to total body
irradiation (TBI) was comparatively studied in GFP transgenic C57BL/6-Tg (CAG-EGFP) mice and C57BL/6 N wild type mice. It
was demonstrated that GFP transgenic mice were more sensitive to radiation-induced bone marrow death, and no adaptive
response could be induced. In the nucleated bone marrow cells of GFP transgenic mice exposed to a middle dose, there was a
significant increase in both the percentage of cells expressing pro-apoptotic gene Bax and apoptotic cell death. While in wild type
cells, lower expression of pro-apoptotic gene Bax and higher expression of anti-apoptotic gene Bcl-2, and significant lower
induction of apoptosis were observed compared to GFP transgenic cells. Results suggest that presence of GFP could alter
response to TBI at whole body, cellular and molecular levels in mice. These findings indicate that there could be a major influence
on the interpretation of the results obtained in GFP transgenic mice.
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Introduction
Since the discovery of green fluorescent protein (GFP), cloning
and subsequent expression of the GFP gene in heterologous
systems have established GFP as a unique genetic reporter and
bioindicator system for use in particular visualizing spatial and
temporal patterns of gene expression in a variety of organisms.
Groundbreaking achievements have been made in biochemical
and medicinal studies using GFP as an invaluable tool, result-
ing in the 2008 Nobel Prize for Chemistry.1 Allowing for non-
invasive monitoring in living and in paraformaldehyde-fixed
cells, nowadays, GFP, its homologues, and some other fluor-
escent proteins are indispensable in many research fields.
Application of GFP as a marker has revolutionized biological
research in the last few decades.2
As a genetic reporter and a bioindicator (biomarker) system
to monitor gene expression and protein localization in living
organisms, GFP gains extensive use in a wide range of research
fields. The transgenic and gene targeting regimes in the varied
lives of organisms have been revolutionized by genetically
encoded non-invasive auto-fluorescent markers. Among these,
GFP offers several advantages over conventional gene-based
reporters, such as lacZ and alkaline phosphatase, due to the fact
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that its visualization does not require a chromogenic substrate
and can be realized in vivo.3 In laboratory mice, for examples,
GFP is used as a vital cell marker to study embryogenesis,4
combinatorial, double-tagged recombination experiments, chi-
meras or transplantations.5 As a fact, studies in biology, phy-
siology, development, pharmacokinetics, oncology and botany
have benefited tremendously from the applications of GFP and
other fluorescent proteins.6-13 Furthermore, in vaccine research
and development, GFP was incorporated into vector construc-
tions to facilitate the recognition of recombinants.14
In radiation biology studies, introduction of GFP as a repor-
ter gene into mammalian cells allows visualization of the mod-
ified gene expression levels, signal transduction rates, cell
metabolism activities, cell cycle phases and cell death, supply-
ing basic information on the cellular response to ionizing radia-
tion (IR). For examples, M phase cancer cells expressing
enhanced GFP-aurora kinase B were used to study the cell
cycle progression caused by an X-ray microbeam.15 GFP trans-
genic medaka fish Oryzias latipes were used in work on the
responses of embryonic germ cells to gamma-rays and of thy-
mus to X-rays and Fe heavy ions.16,17 To determine the poten-
tial of UV light as a therapeutic modality for minimal residual
cancer, which is a major problem in surgical oncology after
apparent tumor curative resection, dual-color cancer cells
expressing GFP in the nucleus and red fluorescent protein in
the cytoplasm were used in the investigation of the UV light
efficacy on the killing of cancer cells.18 Moreover, to under-
stand radiation risks for humans in space, enhanced GFP
(EGFP) was used as a favorable suitability in gene expression
studies on the response of mammalian cells to UVC exposure
in the International Space Station.19 EGFP was applied in cel-
lular monitoring of the nuclear factor kappaB pathway for
assessing the biological effects of accelerated heavy ions as a
model of space environmental radiation conditions.20 In addi-
tion, in some experimental biosystems using lower organisms,
application of hydrozoan Obelia longissima harboring biolu-
minescence reaction and introduction of GFP into bacteria
Deinococcus radiodurans were subjected to evaluation on the
biological effects of chronic low-dose beta radiation from tri-
tiated water and in situ real-time evaluation of radiation-
responsive promoters.21,22
GFP of jellyfish Aequorea victoria is an unusual protein
with visible absorbance and fluorescence. Unlike other report-
ers, GFP fluorescence emerges in the absence of substrates
or cofactors due to that GFP self-contains a fluorescent
p-hydroxybenzylidene-imidazolidinone chromophore in the
peptide chains. As the sensitivity of wild-type GFP is below
that of standard reporter proteins (i.e., beta-galactosidase) uti-
lizing enzymatic amplification, enhancement of wild-type GFP
was achieved by human codon optimization and fluorophore
mutation, leading to higher expression levels and brighter
fluorescence.23 GFP was originally believed to be biologically
inert and no adverse effects were reported in early stud-
ies.14,24,25 However, recent work has suggested the existence
of abnormalities (in terms of cytotoxicity, immunogenicity,
and overall function) in cells and animals overexpressing
GFP.26 For example, FVB/N mice expressing transgenic GFP,
exhibited dilated cardiomyopathy, earlier death, and altered
daily time course of urine, liver and kidney.27,28 In zebrafish
Danio rerio overexpressing GFP, embryonic cardiac malfunc-
tion was observed as well as a defect in aerobic performance in
adults.29 In cells expressing transgenic GFP, studies showed
different baseline of mitochondrial transcript expression in
human T-cell line JURKAT cells, proteome modifications in
breast cancer cell line, apoptosis in NIH/3T3, BHK-21, Huh-7,
and HepG2 cells, protein burden in yeast Saccharomyces cer-
evisiae and myopathy in mouse muscle cells.30-34 In addition,
compared to their wild type counterparts, GFP transgenic cells
showed altered response to insults including IR. For example,
increased oxidative stress and enhanced sensitivity to cytotoxic
drugs in neuroblastoma cell lines and significant difference in
transcriptional regulation of the mitochondrial genes after
exposure to IR were observed.3,30,35 Collectively, these results
suggest that GFP might behave as a confounder which may
affect the interpretation of experimental data.
GFP has been extensively used as reporters, indicators or
markers in radiation biology studies on the assumption that it is
mostly biologically inert in the experimental systems thus no
altered response to radiation would occur or should be consid-
ered in GFP transgenic organisms compared to their wild type
counterparts. However, considerable evidence has gradually
accumulated leading to deepening needs for further clarifica-
tion on this issue. In this work, we comparatively studied the
response of GFP transgenic mice (C57BL/6-Tg (CAG-EGFP))
and their wild type counterpart mice (C57BL/6 N) to X-ray
total body irradiation (TBI).
Materials and Methods
Animals
Both C57BL/6-Tg (CAG-EGFP) mice and C57BL/6 N wild-
type mice were purchased from SLC, Inc. (Japan). The C57BL/
6-Tg (CAG-EGFP) mice were originally produced by Dr.
Okabe and colleagues belonging to line 131, one of the so-
called “green mice” lines.25 In the mouse genome the transgene
integration chromosomal locus was on chromosome 14 D1.36
The enhanced green fluorescent protein (EGFP) was expressed
by the CAG promoter (pCAGGS-EGFP), and almost all tissues
and cells (except erythrocytes and hair) of the animals were
fluoresced bright green.25,37 The mice were reported being
normal and healthy.25 In the present work, the homozygous
animals were used and these mice showed no abnormal phys-
ical appearance and behavioral abnormalities before exposure
to high dose of X-rays. In this paper, the short term “C57BL/
6N-GFP” was used to denote “C57BL/6-Tg (CAG-EGFP).”
C57BL/6 N wild-type (C57BL/6N-WT) mice were used as the
counterparts of the C57BL/6N-GFP mice. Animals were kept
under a 12 h light-12 h dark photoperiod, housed in autoclaved
cages with sterilized wood chips, and allowed to standard
laboratory chow (MB-1, Funabashi Farm Co., Japan) and acid-
ified water (pH ¼ 3.0 + 0.2) ad libitum. Based on the
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preliminary trials, in the present work at least 6 mice of both
genders were used in each experimental point in the cellular
and molecular study. At least 22 mice were used in each experi-
mental group in the 30-day survival test.
All experimental protocols (Experimental Animal Research
Plan No. 11-1003-5 and No. 07-1049-15, and Research Plan
Using Genetically Modified Organisms No. H19-19) involving
mice were reviewed and approved by The Institutional Animal
Care and Use Committee of the National Institute of Radiolo-
gical Sciences, National Institutes for Quantum and Radiolo-
gical Science and Technology (QST-NIRS), Japan. The
experiments were performed in strict accordance with the
QST-NIRS Guidelines for the Care and Use of Laboratory
Animals.
Irradiation
X-rays were generated with an X-ray machine (Pantak-320 S,
Shimadzu, Japan) operated at 200 kVp and 20 mA, using a
0.50 mm Al þ 0.50 mm Cu filter. An exposure-rate meter
(AE-1321 M, Applied Engineering Inc, Japan) with an ioniza-
tion chamber (C-110, 0.6 ml, JARP, Applied Engineering Inc,
Japan) was used for the dosimetry. The mice held in acryl
containers were exposed to total body irradiation (TBI) without
anesthesia at room temperature.
Mouse Model for Radiation-Induced Adaptive Response
Radiation-induced adaptive response (RAR) is one of the spe-
cific phenomena induced by a priming low dose against a sub-
sequent challenge IR at higher doses. To investigate possible
altered response to total body irradiation (TBI) at low and high
doses in C57BL/6N-GFP mice at whole body level, an attempt
was made to induce a RAR using a mouse model for rescue of
bone marrow death (Yonezawa Effect) established by Yone-
zawa and colleagues.38 In brief, a priming dose at 0.5 Gy was
delivered to the animals on postnatal age of 6 weeks followed
by a lethal challenge high dose at 7.5 Gy on postnatal age of
8 weeks. The dose rate was at about 0.30 Gy/min for delivering
the priming dose was and 0.90 Gy/min for the challenge dose.
A successful induction of RAR was judged as a significant
reduced mortality observed in the animals receiving both the
priming and challenge doses compared to the animals receiving
only the challenge dose in the 30-day survival test.
Collection and Fixation of the Nucleated Bone
Marrow Cells
To measure altered response to TBI in C57BL/6N-GFP mice at
cellular and molecular levels, gene expression, distribution of
cells in the different phases of the cell cycle, and apoptotic cell
death were analyzed by flow cytometry in the nucleated bone
marrow cells collected from animals exposed to a non-lethal
high dose at 4.5 Gy or sham-irradiated at the indicated times. In
brief, mice were euthanized by CO2 asphyxiation 3 h or 6 h
after TBI. Both femurs of each mouse were removed and the
bone marrow tissues were collected by flushing femurs with
phosphate buffered saline free from calcium and magnesium
ions (PBS (-)). Single cell suspensions of dissociated nucleated
bone marrow cells in PBS (-) were filtered through a 40 mm cell
strainer (Corning, Inc, USA) after treating bone marrow tissues
with tris-buffered ammonium chloride for the lysis of erythro-
cytes and washing with PBS (-). The nucleated bone marrow
cells were then fixed for at least 24 h with either 1% parafor-
maldehyde phosphate buffer solution (Wako Pure Chemical
Industries, Ltd, Japan) at 4 C for assessment of gene expres-
sion or ice-cold 70% ethanol at -20 C for measurement of cell
cycle distribution and apoptosis.
Flow Cytometric Analysis of Gene Expression, Cell Cycle
Distribution and Cell Death
For analysis of gene expression, cells were collected 3 h after
TBI, fixed with a paraformaldehyde phosphate buffer solution
and washed twice with PBS (-). Cells were then permeabilized
in 0.1% Triton X-100 and blocked for 1 h at room temperature
with 1% bovine serum albumin to prevent non-specific bind-
ing. Then cells were incubated overnight at 4 C with primary
monoclonal antibodies: anti-p53 (PAb122) (Enzo Life
Sciences, Inc, USA), anti-p21 (F-5) (Santa Cruz Biotechnol-
ogy, Inc, USA), anti-Bcl-2 (C2) (Santa Cruz Biotechnology,
Inc, USA), or anti-Bax (B-9) (Santa Cruz Biotechnology, Inc,
USA), diluted at different concentrations. On the following
day, cells were washed twice with PBS (-) followed by a further
incubation with a goat anti-mouse IgG (HþL) APC secondary
antibody (Southern Biotechnology Associates, Inc. USA)
diluted 1:200 in PBS (-) containing 1% bovine serum albumin
for 1 h in the dark at room temperature. The control was pre-
pared in an identical way except that primary antibody was
replaced by an isotype-specific mouse IgG1 monoclonal anti-
body (PB100) (Sigma-Aldrich, Japan) to discriminate between
specific and non-specific fluorescence for the proteins mea-
sured. For analysis of cell cycle distribution and apoptosis (sub
G1), cells collected 6 h after TBI and fixed with ethanol were
incubated with 30 mg/ml propidium iodide (Sigma-Aldrich,
Japan) and 50 mg/ml ribonuclease A (Sigma-Aldrich, Japan)
for 30 min at 37C in the dark. Before flow cytometric analysis,
cells were washed and re-suspended in PBS (-). Cell cycle
parameters and positively stained cells for protein expression
were analyzed using a FACSCalibur flow cytometer (BD Bios-
ciences, Franklin Lakes, NJ, USA) with BD FACStation™
software version 6.1. Total 50,000 cells were analyzed in each
sample.
Statistical Analysis
Error propagation formula for subtraction was used to calculate
increase in percentage of apoptosis and positive stained cells
expressing proteins tested after TBI, and error propagation for-
mula for division was used to calculate the ratio of Bax to Bcl-
2. Statistical evaluation of the data was done using Chi-squared
test for the 30-day survival, analysis of variance (ANOVA) for
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the intergroup differences and Student’s t-test for the difference
between 2 groups for induction of apoptosis and gene expres-
sion. The statistical significance was assigned to P < 0.05.
Results
Validation of Responses to TBI of C57BL/6N-WT and
C57BL/6N-GFP Mice
Responses to TBI at whole body level were studied in C57BL/
6N-WT mice (Figure 1) and C57BL/6N-GFP mice (Figure 2)
using 30-day survival test as the endpoint. Reproducibility of
the RAR mouse model (Yonezawa Effect) in C57BL/6N-WT
mice was verified and confirmed in both the females
(Figure 1A) and the males (Figure 1B). The survival rate was
66.7% and 60.0% respectively for female and male animals
receiving a priming dose of 0.5 Gy X-rays at postnatal 6 weeks
followed by a challenge dose of 7.5 Gy X-rays at postnatal 8
weeks. The survival rate was 6.7% and 10.0% respectively for
female and male animals receiving only the challenge dose of
7.5 Gy at postnatal 8 weeks. Results showed that administration
of the priming dose induced a significant increase in the
Figure 1. Thirty-day survival test after a challenge dose of 7.5 Gy in
C57BL/6N-WT mice. Effect of a priming dose of 0.5 Gy X-rays on a
subsequent challenge dose of 7.5 Gy X-rays on mouse 30-day survival
was verified in both female (A) and male (B) animals. The solid line
denotes the animals (4 females and 4 males) that were untreated with
TBI. The dotted line represents the animals (30 females and 30 males)
that were irradiated with only the challenge dose at postnatal 8 weeks.
The broken line stands for the animals (30 females and 30 males) that
were primed with a dose of 0.5 Gy X-rays at postnatal 6 weeks
followed by a challenge dose of 7.5 Gy X-rays at postnatal 8 weeks.
Two asterisks (**) indicate statistically significant differences (P < 0.01)
between the 2 groups that were compared.
Figure 2. Thirty-day survival test after a challenge dose of 7.5 Gy in
C57BL/6N-GFP mice. Effect of a priming dose of 0.5 Gy X-rays on a
subsequent challenge dose of 7.5 Gy X-rays on mouse 30-day survival
was verified in both female (A) and male (B) animals. The solid line
denotes the animals (4 females and 4 males) that were untreated with
IR. The dotted line represents the animals (25 females and 33 males)
that were irradiated with only the challenge dose at postnatal 8 weeks.
The broken line stands for the animals (33 females and 33 males) that
were primed with a dose of 0.5 Gy X-rays at postnatal 6 weeks
followed by the challenge dose at postnatal 8 weeks. Two asterisks
(**) indicate statistically significant differences (P < 0.01) between the
2 groups that were compared.
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survival rate, namely, 60.0% in female and 50.0% in male.
These results clearly indicated that RAR was successfully
demonstrated in C57BL/6N-WT mice of both genders in our
experimental setup.
On the other hand, the survival rate was zero for both female
(Figure 2A) and male (Figure 2B) GFP animals receiving a
priming dose of 0.5 Gy X-rays followed by a challenge dose
of 7.5 Gy X-rays. The survival rate was zero and 3.0% respec-
tively for female and male animals receiving only the challenge
dose. Results showed that administration of the priming dose
did not induce any increase in the survival rate in both female
and male animals. These results clearly indicated that no RAR
was demonstrated in C57BL/6N-GFP mice of both genders.
It is noticed that after exposure to TBI at the same lethal
dose (7.5 Gy), C57BL/6N-GFP mice appeared more sensitive
to IR-induced killing than the C57BL/6N-WT mice, namely,
no female animal and 3.0% of male animals survived in the 30-
day survival test in C57BL/6N-GFP mice while 6.7% of the
females and 10.0% of the males survived in C57BL/6N-WT
mice. In addition, most of the death cases occurred either ear-
lier, or in a short period of time in C57BL/6N-GFP mice. For
examples, in C57BL/6N-GFP mice receiving the lethal TBI,
the first death case occurred on the 7th day for both genders,
and 80% death occurred within the 13th day for female and
within the 12th day for male animals. While in C57BL/6N-WT
mice, the first death case appeared on the 9th day in female and
on the 7th day in male animals, and 80% deaths occurred within
the 15th day in the females and within the 14th day in the
males. Furthermore, to exclude a possibility which the chal-
lenge dose at 7.5 Gy was too high to validate existence of RAR
in C57BL/6N-GFP mice, 2 lower doses at 7.0 Gy and 6.5 Gy
were also tested, and no RAR was induced (data not shown).
All these findings indicated altered response to TBI at both
low and high doses at whole body level measured as 30-day
survival in C57BL/6N-GFP mice compared to C57BL/6N-WT
mice.
Induction of Apoptotic Cells and Change of
Cell Cycle Distribution in the Nucleated Bone Marrow
Cells After TBI
Percentage of apoptotic nucleated bone marrow cells was ana-
lyzed flow cytometrically by measuring cellular DNA content
via fluorescent DNA-binding dye propidium iodide. Cells were
collected from C57BL/6N-WT and C57BL/6N-GFP mice 6 h
after TBI with a nonlethal middle dose at 4.5 Gy (Figure 3).
Figure 3A showed some of the representative histogram images
obtained in flow cytometry. In the cells from both C57BL/6N-
WT and C57BL/6N-GFP mice, background level of apoptosis
was very low while it was slightly higher in C57BL/6N-GFP
mice. After 4.5 Gy-TBI a significant increase in apoptosis in
the cells from both C57BL/6N-WT mice and C57BL/6N-GFP
mice, namely, from 1.0% to 12.6% (12.6-fold increase) in
C57BL/6N-WT mice and from 1.2% to 29.3% (24.4-fold
increase) in C57BL/6N-GFP mice. In addition, a significant
decreased bone marrow cellularity (total number of nucleated
cells) was observed in both C57BL/6N-WT mice and C57BL/
6N-GFP mice while the magnitude of cellularity reduction was
markedly higher in C57BL/6N-GFP mice (data not shown).
The increase apoptotic fraction in C57BL/6N-GFP mice was
markedly higher than that in C57BL/6N-WT mice. These
results clearly indicated that significantly increased apoptosis
was induced in the nucleated bone marrow cells in both
C57BL/6N-WT and C57BL/6N-GFP mice after TBI, and the
cells from C57BL/6N-GFP mice were more sensitive to IR-
induced cell death compared to that from C57BL/6N-WT mice.
Analysis of cell cycle distribution was performed flow cyto-
metrically by measuring cellular DNA content via fluorescent
DNA-binding dye propidium iodide in the nucleated bone
Figure 3. Number of apoptotic cells in the nucleated bone marrow
cells in C57BL/6N-WT and C57BL/6N-GFP mice 6 h after 4.5Gy-TBI.
Validation of apoptotic cell appearance was performed by flow cyto-
metry. At least 6 samples from both female and male mice were
measured at each time point in each group. The representative histo-
gram images were shown in panel A. Results were shown in bar graphs
in panel B. Two asterisks (**) indicate statistically significant differ-
ences (P < 0.01) between the 2 groups that were compared.
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marrow cells collected from C57BL/6N-WT and C57BL/6N-
GFP mice 6 h after TBI with a nonlethal dose at 4.5 Gy (Fig-
ure 4). The representative histogram images were shown in
Figure 4A. Without TBI, no significant difference in the dis-
tribution of cells in each of cycle phase was observed in both
C57BL/6N-WT and C57BL/6N-GFP mice. Six h after TBI,
there was a significant decrease in percentage of cells in G0/
G1 phase for both C57BL/6N-WT and C57BL/6N-GFP mice.
A marked increase was observed in the percentage of S phase
cells in C57BL/6N-GFP mice (from 5.8% to 9.1%) and of G2/
M phase cells in C57BL/6N-WT mice (from 5.7% to 12.8%).
The increase was statistically significant between the cells from
C57BL/6N-GFP mice and C57BL/6N-WT mice. These results
clearly indicated that TBI induced an S phase arrest in the
nucleated bone marrow cells in C57BL/6N-GFP mice and a
G2/M phase arrest in C57BL/6N-WT mice.
All these findings indicated altered response to TBI at a
moderate dose at cellular level measured as apoptosis and cell
cycle distribution in the nucleated bone marrow cells in
C57BL/6N-GFP mice compared to that in C57BL/6N-WT
mice.
Induction of Cells Expressing Tested Genes in the
Nucleated Bone Marrow Cells After TBI
Percentage of positive immunohistochemically stained cells
expressing tested genes in the nucleated bone marrow cells
from C57BL/6N-WT mice (Figure 5A) and C57BL/6N-GFP
mice (Figure 5B) 3 h after TBI was performed flow
Figure 4. Change of cell cycle phases in the nucleated bone marrow
cells in C57BL/6N-WT and C57BL/6N-GFP mice 6 h after 4.5Gy-TBI.
Validation of cell cycle phases in the cells was performed by flow
cytometry. At least 6 samples from both female and male mice were
measured at each time point in each group. The representative histo-
gram images were shown in panel A. Results were shown in bar graphs
in panel B. One asterisk (*) and 2 asterisks (**) indicate respectively
statistical differences at P < 0.05 and P < 0.01 between the 2 groups
that were compared.
Figure 5. Percentage of positive cells expressing tested proteins in
the nucleated bone marrow cells in C57BL/6N-WT (A) and C57BL/
6N-GFP (B) mice 3 h after 4.5Gy-TBI. Validation of positive immuno-
histochemically stained cell appearance in the cells was performed
flow cytometrically. At least 6 samples from both female and male
mice were measured in each group. One asterisk (*) indicates statis-
tical differences at P < 0.05 between the 2 groups that were
compared.
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cytometrically. Without TBI, the background levels of P53 was
slightly higher in the cells from C57BL/6N-WT mice while the
background level of Bax was slightly higher in the cells from
C57BL/6N-GFP mice. Three hours after TBI, there was a sig-
nificant increase in the percentage of cells expressing cyclin-
dependent kinase inhibitor P21 and Bax in the cells from
C57BL/6N-GFP mice. In C57BL/6N-WT mice, increase in the
percentage of cells expressing P21 and Bcl-2 was observed
and the increase was at the margin of statistical significance
(P ¼ 0.05).
Of note, the background ratio of Bax to Bcl-2 was 0.42 and
0.37 respectively in the cells from C57BL/6N-GFP mice and
their counterparts. After TBI the ratio increased 50.0% to 0.63
in the cells from C57BL/6N-GFP mice and 18.9% to 0.44 in the
cells from C57BL/6N-GFP mice and C57BL/6N-WT mice,
respectively. These results suggested that in response to TBI
at a middle dose, there was a significant higher expression of
pro-apoptotic gene Bax in the nucleated bone marrow cells in
C57BL/6N-GFP mice while a higher expression of anti-
apoptotic gene Bcl-2 in the cells from the C57BL/6N-WT
mice.
All these findings indicated alterations at molecular level
measured as gene expression in response to TBI at a moderate
dose in C57BL/6N-GFP mice compared to the C57BL/6N-WT
mice.
Discussion
GFP was discovered in 1961 as a byproduct of the extraction of
aequorin from jellyfish Auquorea Victoria.39 While it is one of
the most important tools in biology and many transgenic organ-
isms from prokaryotic cells to eukaryotic animals have been
developed using GFP technologies, in particular, the EGFP
which is one of the engineered variants of the original wild
type GFP gene with improved thermostability and fluores-
cence. To date, Escherichia coli, yeast, cultured cells, Caenor-
habditis elegans, Drosophila, butterfly Junonia orithya,
zebrafish, medaka Oryzias latipes, mice, rats, rabbits, lambs,
pigs and monkeys are available as GFP transgenic models.25,40-
50 The laboratory mouse is one of the premier mammalian
model organisms, and EGFP is popularly used in producing
transgenic or targeted mice to create mutations at base pair
resolution and tag different cellular populations.6 Use of GFP
and its color variants as reporters and indicators is challenging
genome engineering technology and enabling novel
approaches in life science studies. On the other hand, applica-
tion of the GFP transgenic animal models should be verified
and considered as these animals could also impose some uncer-
tainties and limitations on their applicability due to alterations
in the biological properties and functions compared to their
wild type counterparts. It should be also noticed that there is
also a possibility that alterations of GFP transgenic animals in
the biological properties and functions were not only due to
expression of GFP. For example, although the animals looked
healthy, integration of GFP plasmid might modify the local
chromosome conformation near its locus, directly or indirectly
affecting the transcripts of certain genes for important func-
tions such as DNA damage responses. Further work should be
done to clarify this point whenever possible using more stains
of transgenic animals in which the GFP is located at different
genome loci, or with other reliable experimental strategies.
To verify if there are any altered response of GFP transgenic
mice to TBI, a mouse model for RAR (Yonezawa Effect) was
adopted and applied to this work using C57BL/6N-GFP mice,
the first engineered GFP transgenic mice in the world with
applications in a wide range of research fields including radia-
tion biology.25,51-63 RAR is a phenomenon that pre-exposure to
a low priming dose reduces the biological effects of a subse-
quent higher challenge dose. Since the discovery of RAR,64 it
has been demonstrated in a variety of biosystems from simple
prokaryotes to higher eukaryotes including mammalian ani-
mals with varied endpoints including cell death and bone mar-
row death.65-68 The mouse RAR model (Yonezawa Effect) is a
well-designed system in investigating response of the mice to
IR of both low and high doses using endpoints at molecular,
cellular and whole body levels.38,69-74 There are 2 different
phenotypes of RAR in this model involving different mechan-
isms: the first phenotype could be induced by a low priming
dose at 0.30-0.50 Gy leading to radioresistance in blood form-
ing tissues 2 weeks later, and the second phenotype could be
induced by a very low priming dose at 0.05-0.10 Gy 2 months
later. The model for the first phenotype was used to compara-
tively study the response in the GFP transgenic mice to TBI
with that in their wild type counterparts. GFP transgenic mice
showed altered response to the isodose at all endpoints includ-
ing bone marrow death, induction of adaptive response, and
induction of apoptosis and gene expression in the nucleated
bone marrow cells.
Taken into consideration the documented studies on
changes of biological properties and physiological functions
in GFP transgenic cells and animals due mainly to increased
reactive oxygen species (ROS) induced by GFP overexpres-
sion,75 ROS may involve at least in a part of the mechanisms
underlying alterations in response of GFP transgenic mice to
TBI in the present work. ROS are highly reactive molecules,
playing important roles in many biological and signaling pro-
cesses. In a healthy cell there is a balance between generation
and neutralization of ROS by endogenous cellular defense
machinery, and low levels of ROS inside the cell are required
for physiological functioning to regulate signaling mechanisms
involved in mitosis and apoptosis. However, when intracellular
redox imbalance occurs due to such as excess of ROS produc-
tion and inefficiency of antioxidant defenses, increased ROS
could induce oxidative stress causing structural damage to the
surrounding vital cellular molecules, including cytosolic lipids,
proteins and DNA. This would lead to dysregulation of phy-
siological functions and increased vulnerability to detrimental
health outcomes.76 Mitochondria are the major source of ROS
within a cell and a major target of ROS, subjecting to high
levels of ROS-induced damage. Furthermore, damage of
enzymes in the electron transport chain of the mitochondria
would in turn induce further ROS production.77 Increased
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levels of ROS could induce higher radiosensitivity.77 In model
mice expressing elevated levels of ROS, increased radiosensi-
tivity was demonstrated, which was mediated via dysregulation
of antioxidant response and defective redox homeostasis.69-79
These animals showed increased apoptosis of hematopoietic
progenitor and stem cells, and elevated lethality after TBI com-
pared to their counterparts.78 Embryonic fibroblasts from the
model mice expressed elevated levels of ROS at basal levels
and after exposure to IR, correlating with increased apoptosis
and decreased clonogenic survival.80 In transgenic cells stably
expressing GFP, steady synthesis and maturation of GFP and
GFP redox cycling activity occur, causing increased formation
ROS compared to the wild-type cells, leading to cytotoxicity
and tissue abnormalities.75 Increase in the steady state levels of
ROS could cause activation of Bax and caspases, leading to
induced apoptosis.81 In this work, elevated level of both the
percentage of cells expressing Bax and apoptotic cells was
observed in the bone marrow from C57BL/6N-GFP mice com-
pared to that in their wild type counterparts. These results
indicated a causal connection between gene activation and
apoptosis induction. These findings also suggested that the
Bax/Bcl-2 switch was flipped in cells from C57BL/6N-GFP
mice, possibly by increased ROS, to contribute to the induced
apoptosis. Furthermore, increased ROS could activate multiple
signal transduction pathways.82 ROS stress itself may also
increase the levels of other stress-inducible second messengers.
As key signaling molecules, ROS play an important role in the
progression of inflammatory disorders. Elevations in total leu-
kocyte count, a reliable biomarker of inflammation, are signif-
icantly in response to inflammation.83,84 Enhanced generation
of ROS by polymorphonuclear neutrophils could cause
endothelial dysfunction and tissue injury.85 In fact, in our pre-
liminary study on the total leukocyte count in peripheral blood
histogram, no significant difference was found between
C57BL/6N-GFP mice and C57BL/6N-WT mice at postnatal
age of 6-8 weeks while the count was more than twice higher
in C57BL/6N-GFP mice than that in their counterparts at post-
natal age of 10 months (data not shown). These results sug-
gested possible induction of chronic inflammation in C57BL/
6N-GFP mice. Equally significant and interesting, many stud-
ies with in vitro and in vivo systems demonstrate enhanced
ROS formation and altered responses of oxidative stress and
inflammation genes of GFP transgenic cells and animals to
cytotoxic or genotoxic insults including IR.86 Thus, in the case
of C57BL/6N-GFP mice exposed to TBI, GFP-induced ROS
could be an agonist to IR-induced ROS, conveying more infor-
mation transduced into the cell to activate pro-apoptotic and
inflammatory responses, causing cellular damage triggering
and enhancing induction of apoptosis, resulting in increased
lethality to radiation-induced bone marrow death.
Although the exact mechanisms underlying altered response
of GFP transgenic mice to IR warranted for further studies, it
does not affect in any way the conclusion of the present work:
enhanced expression of GFP in transgenic cells and animals is
not innoxious and investigation using these organisms should
be seriously taken into consideration in the study of radiation
biology. In summary, although being not yet proven totally
untrue, normalness and healthiness in physiological function-
ing and pathological responses of GFP transgenic cells and
animals compared to their wild-type counterparts have cer-
tainly not been proven to be true. Under these circumstances,
even taking into account the great achievements obtained by
GFP transgenic technologies, it is non-negligible that applica-
tion of GFP in life science research should be highly concerned.
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